Keren Rouvinov
About
In The Last Decade
Keren Rouvinov
43 papers receiving 360 citations
Peers
Comparison fields: 5 of 57
- Oncology 190
- Pulmonary and Respiratory Medicine 178
- Surgery 90
- Molecular Biology 81
- Cancer Research 67
Countries citing papers authored by Keren Rouvinov
This map shows the geographic impact of Keren Rouvinov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keren Rouvinov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keren Rouvinov more than expected).
Fields of papers citing papers by Keren Rouvinov
This network shows the impact of papers produced by Keren Rouvinov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keren Rouvinov. The network helps show where Keren Rouvinov may publish in the future.
Co-authorship network of co-authors of Keren Rouvinov
This figure shows the co-authorship network connecting the top 25 collaborators of Keren Rouvinov. A scholar is included among the top collaborators of Keren Rouvinov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keren Rouvinov. Keren Rouvinov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 3 | |
| 3 | 6 | |
| 4 | 8 | |
| 5 | 1 | |
| 6 | 7 | |
| 7 | 10 | |
| 8 | 3 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | 8 | |
| 12 | 17 | |
| 13 | 37 | |
| 14 | 10 | |
| 15 | 0 | |
| 16 | 17 | |
| 17 | 1 | |
| 18 | 8 | |
| 19 | Experience with sunitinib treatment for metastatic renal cell carcinoma in a large cohort of Israeli patients: outcome and associated factors. | 9 |
| 20 | 51 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.